Dissecting epigenetic silencing complexity in the mouse lung cancer suppressor gene cadm1

PLoS ONE

Volumn 7, Issue 6, 2012, Pages

  Reamon Buettner, Stella Marie ^a   Borlak, Juergen ^a,b  

^a FRAUNHOFER INSTITUTE FOR TOXICOLOGY AND EXPERIMENTAL MEDICINE   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ADHESION MOLECULE; DNA METHYLTRANSFERASE; HISTONE H2A; NAKED DNA; TRANSCRIPTION FACTOR SP1; TRANSCRIPTION FACTOR SP3; CELL ADHESION MOLECULE 1, MOUSE; DNA (CYTOSINE 5) METHYLTRANSFERASE; DNA MODIFICATION METHYLASE SSSI; HISTONE; IMMUNOGLOBULIN; TUMOR SUPPRESSOR PROTEIN;

ANIMAL EXPERIMENT; ARTICLE; BINDING SITE; CADM1 GENE; CANCER CELL CULTURE; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; DNA SEQUENCE; EMBRYO; EMBRYONIC STEM CELL; EPIGENETICS; GENE AMPLIFICATION; GENE EXPRESSION; GENE REPRESSION; GENE SILENCING; HISTONE MODIFICATION; HUMAN; HUMAN CELL; LUNG CANCER; LUNG TUMOR; MOUSE; NONHUMAN; NUCLEOSOME; PROMOTER REGION; PROTEIN DNA BINDING; PROTEIN DOMAIN; PROTEIN MODIFICATION; TUMOR GENE; ANIMAL; BIOLOGY; GENETICS; METABOLISM; PHYSIOLOGY; TUMOR CELL LINE;

ANIMALS; BINDING SITES; CELL ADHESION MOLECULES; CELL LINE, TUMOR; CHROMATIN IMMUNOPRECIPITATION; COMPUTATIONAL BIOLOGY; DNA METHYLATION; DNA-CYTOSINE METHYLASES; GENE SILENCING; HISTONES; IMMUNOGLOBULINS; LUNG NEOPLASMS; MICE; NUCLEOSOMES; PROMOTER REGIONS, GENETIC; TUMOR SUPPRESSOR PROTEINS;

EID: 84862027801     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0038531     Document Type: Article

References (77)

1. Gomperts BN, Spira A, Massion PP, Walser TC, Wistuba II, et al. (2011) Evolving concepts in lung carcinogenesis. Semin Respir Crit Care Med 32: 32-43.
2. Sharma S, Kelly TK, Jones PA, (2010) Epigenetics in cancer. Carcinogenesis 31: 27-36.
3. Rodriguez-Paredes M, Esteller M, (2011) Cancer epigenetics reaches mainstream oncology. Nat Med 17: 330-339.
4. Portela A, Esteller M, (2010) Epigenetic modifications and human disease. Nat Biotechnol 28: 1057-1068.
5. Andrews AJ, Luger K, (2011) Nucleosome structure(s) and stability: variations on a theme. Annu Rev Biophys 40: 99-117.
6. Segal E, Widom J, (2009) What controls nucleosome positions? Trends Genet 25: 335-343.
7. Arya G, Maitra A, Grigoryev SA, (2010) A structural perspective on the where, how, why, and what of nucleosome positioning. J Biomol Struct Dyn 27: 803-820.
8. Bai L, Morozov AV, (2010) Gene regulation by nucleosome positioning. Trends Genet 26: 476-483.
9. Robertson KD, (2005) DNA methylation and human disease. Nat Rev Genet 6: 597-610.
10. Tahiliani M, Koh KP, Shen Y, Pastor WA, Bandukwala H, et al. (2009) Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1. Science 324: 930-935.
11. Kriaucionis S, Heintz N, (2009) The nuclear DNA base 5-hydroxymethylcytosine is present in Purkinje neurons and the brain. Science 324: 929-930.
12. Ito S, Shen L, Dai Q, Wu SC, Collins LB, et al. (2011) Tet proteins can convert 5-methylcytosine to 5-formylcytosine and 5-carboxylcytosine. Science 333: 1300-1303.
13. Choy JS, Wei S, Lee JY, Tan S, Chu S, et al. (2010) DNA methylation increases nucleosome compaction and rigidity. J Am Chem Soc 132: 1782-1783.
14. Jurkowska RZ, Jurkowski TP, Jeltsch A, (2011) Structure and function of mammalian DNA methyltransferases. Chembiochem 12: 206-222.
15. Chodavarapu RK, Feng S, Bernatavichute YV, Chen PY, Stroud H, et al. (2010) Relationship between nucleosome positioning and DNA methylation. Nature 466: 388-392.
16. Felle M, Hoffmeister H, Rothammer J, Fuchs A, Exler JH, et al. (2011) Nucleosomes protect DNA from DNA methylation in vivo and in vitro. Nucleic Acids Res 39: 8355-8365.
17. Sharma S, De Carvalho DD, Jeong S, Jones PA, Liang G, (2011) Nucleosomes containing methylated DNA stabilize DNA methyltransferases 3A/3B and ensure faithful epigenetic inheritance. PLoS Genet 7: e1001286.
18. Bartke T, Vermeulen M, Xhemalce B, Robson SC, Mann M, et al. (2010) Nucleosome-interacting proteins regulated by DNA and histone methylation. Cell 143: 470-484.
19. Talbert PB, Henikoff S, (2010) Histone variants- ancient wrap artists of the epigenome. Nat Rev Mol Cell Biol 11: 264-275.
20. Zlatanova J, Thakar A, (2008) H2A.Z: view from the top. Structure 16: 166-179.
21. Svotelis A, Gevry N, Gaudreau L, (2009) Regulation of gene expression and cellular proliferation by histone H2A.Z. Biochem Cell Biol 87: 179-188.
22. Draker R, Cheung P, (2009) Transcriptional and epigenetic functions of histone variant H2A.Z. Biochem Cell Biol 87: 19-25.
23. Szenker E, Ray-Gallet D, Almouzni G, (2011) The double face of the histone variant H3.3. Cell Res 21: 421-434.
24. Suganuma T, Workman JL, (2011) Signals and combinatorial functions of histone modifications. Annu Rev Biochem 80: 473-499.
25. Yun M, Wu J, Workman JL, Li B, (2011) Readers of histone modifications. Cell Res 21: 564-578.
26. Fullgrabe J, Kavanagh E, Joseph B, (2011) Histone onco-modifications. Oncogene 30: 3391-3403.
27. Murakami Y, (2005) Involvement of a cell adhesion molecule, TSLC1/IGSF4, in human oncogenesis. Cancer Sci 96: 543-552.
28. Liang QL, Chen GQ, Li ZY, Wang BR, (2011) Function and histopathology of a cell adhesion molecule TSLC1 in cancer. Cancer Invest 29: 107-112.
29. Reamon-Buettner SM, Borlak J, (2008) Epigenetic silencing of cell adhesion molecule 1 in different cancer progenitor cells of transgenic c-Myc and c-Raf mouse lung tumors. Cancer Res 68: 7587-7596.
30. Lin JC, Jeong S, Liang G, Takai D, Fatemi M, et al. (2007) Role of nucleosomal occupancy in the epigenetic silencing of the MLH1 CpG island. Cancer Cell 12: 432-444.
31. Fatemi M, Pao MM, Jeong S, Gal-Yam EN, Egger G, et al. (2005) Footprinting of mammalian promoters: use of a CpG DNA methyltransferase revealing nucleosome positions at a single molecule level. Nucleic Acids Res 33: e176.
32. Gal-Yam EN, Jeong S, Tanay A, Egger G, Lee AS, et al. (2006) Constitutive nucleosome depletion and ordered factor assembly at the GRP78 promoter revealed by single molecule footprinting. PLoS Genet 2: e160.
33. Pondugula S, Kladde MP, (2008) Single-molecule analysis of chromatin: changing the view of genomes one molecule at a time. J Cell Biochem 105: 330-337.
34. Carey M, Smale ST, (2007) Micrococcal nuclease-southern blot assay: I. MNase and restriction digestions. CSH Protoc 2007 doi:10.1101/pdb.prot4890.
35. Jin C, Zang C, Wei G, Cui K, Peng W, et al. (2009) H3.3/H2A.Z double variant-containing nucleosomes mark 'nucleosome-free regions' of active promoters and other regulatory regions. Nat Genet 41: 941-945.
36. Haring M, Offermann S, Danker T, Horst I, Peterhansel C, et al. (2007) Chromatin immunoprecipitation: optimization, quantitative analysis and data normalization. Plant Methods 3: 11.
37. Gaulton KJ, Nammo T, Pasquali L, Simon JM, Giresi PG, et al. (2010) A map of open chromatin in human pancreatic islets. Nat Genet 42: 255-259.
38. Zhang Y, Moqtaderi Z, Rattner BP, Euskirchen G, Snyder M, et al. (2009) Intrinsic histone-DNA interactions are not the major determinant of nucleosome positions in vivo. Nat Struct Mol Biol 16: 847-852.
39. Kaplan N, Moore I, Fondufe-Mittendorf Y, Gossett AJ, Tillo D, et al. (2010) Nucleosome sequence preferences influence in vivo nucleosome organization. Nat Struct Mol Biol 17: 918-920.
40. Zhang Z, Wippo CJ, Wal M, Ward E, Korber P, et al. (2011) A packing mechanism for nucleosome organization reconstituted across a eukaryotic genome. Science 332: 977-980.
41. Kaplan N, Moore IK, Fondufe-Mittendorf Y, Gossett AJ, Tillo D, et al. (2009) The DNA-encoded nucleosome organization of a eukaryotic genome. Nature 458: 362-366.
42. Steward N, Sano H, (2004) Measuring changes in chromatin using micrococcal nuclease. Methods Mol Biol 287: 65-75.
43. Clark DJ, (2010) Nucleosome positioning, nucleosome spacing and the nucleosome code. J Biomol Struct Dyn 27: 781-793.
44. Yuan GC, Liu YJ, Dion MF, Slack MD, Wu LF, et al. (2005) Genome-scale identification of nucleosome positions in S. cerevisiae. Science 309: 626-630.
45. Henikoff S, (2009) Labile H3.3+H2A.Z nucleosomes mark 'nucleosome-free regions'. Nat Genet 41: 865-866.
46. Raisner RM, Hartley PD, Meneghini MD, Bao MZ, Liu CL, et al. (2005) Histone variant H2A.Z marks the 5′ ends of both active and inactive genes in euchromatin. Cell 123: 233-248.
47. Barski A, Cuddapah S, Cui K, Roh TY, Schones DE, et al. (2007) High-resolution profiling of histone methylations in the human genome. Cell 129: 823-837.
48. Schones DE, Cui K, Cuddapah S, Roh TY, Barski A, et al. (2008) Dynamic regulation of nucleosome positioning in the human genome. Cell 132: 887-898.
49. Gevry N, Hardy S, Jacques PE, Laflamme L, Svotelis A, et al. (2009) Histone H2A.Z is essential for estrogen receptor signaling. Genes Dev 23: 1522-1533.
50. Kelly TK, Miranda TB, Liang G, Berman BP, Lin JC, et al. (2010) H2A.Z maintenance during mitosis reveals nucleosome shifting on mitotically silenced genes. Mol Cell 39: 901-911.
51. Creyghton MP, Markoulaki S, Levine SS, Hanna J, Lodato MA, et al. (2008) H2AZ is enriched at polycomb complex target genes in ES cells and is necessary for lineage commitment. Cell 135: 649-661.
52. Thakar A, Gupta P, McAllister WT, Zlatanova J, (2010) Histone variant H2A.Z inhibits transcription in reconstituted nucleosomes. Biochemistry 49: 4018-4026.
53. Marques M, Laflamme L, Gervais AL, Gaudreau L, (2010) Reconciling the positive and negative roles of histone H2A.Z in gene transcription. Epigenetics 5: 267-272.
54. Zilberman D, Coleman-Derr D, Ballinger T, Henikoff S, (2008) Histone H2A.Z and DNA methylation are mutually antagonistic chromatin marks. Nature 456: 125-129.
55. Zemach A, McDaniel IE, Silva P, Zilberman D, (2010) Genome-wide evolutionary analysis of eukaryotic DNA methylation. Science 328: 916-919.
56. Conerly ML, Teves SS, Diolaiti D, Ulrich M, Eisenman RN, et al. (2010) Changes in H2A.Z occupancy and DNA methylation during B-cell lymphomagenesis. Genome Res 20: 1383-1390.
57. Weber CM, Henikoff JG, Henikoff S, (2010) H2A.Z nucleosomes enriched over active genes are homotypic. Nat Struct Mol Biol 17: 1500-1507.
58. Thakar A, Gupta P, Ishibashi T, Finn R, Silva-Moreno B, et al. (2009) H2A.Z and H3.3 histone variants affect nucleosome structure: biochemical and biophysical studies. Biochemistry 48: 10852-10857.
59. Chi P, Allis CD, Wang GG, (2010) Covalent histone modifications-miswritten, misinterpreted and mis-erased in human cancers. Nat Rev Cancer 10: 457-469.
60. Bernstein BE, Mikkelsen TS, Xie X, Kamal M, Huebert DJ, et al. (2006) A bivalent chromatin structure marks key developmental genes in embryonic stem cells. Cell 125: 315-326.
61. Mikkelsen TS, Ku M, Jaffe DB, Issac B, Lieberman E, et al. (2007) Genome-wide maps of chromatin state in pluripotent and lineage-committed cells. Nature 448: 553-560.
62. Pan G, Tian S, Nie J, Yang C, Ruotti V, et al. (2007) Whole-genome analysis of histone H3 lysine 4 and lysine 27 methylation in human embryonic stem cells. Cell Stem Cell 1: 299-312.
63. Zhao XD, Han X, Chew JL, Liu J, Chiu KP, et al. (2007) Whole-genome mapping of histone H3 Lys4 and 27 trimethylations reveals distinct genomic compartments in human embryonic stem cells. Cell Stem Cell 1: 286-298.
64. Wei G, Wei L, Zhu J, Zang C, Hu-Li J, et al. (2009) Global mapping of H3K4me3 and H3K27me3 reveals specificity and plasticity in lineage fate determination of differentiating CD4+ T cells. Immunity 30: 155-167.
65. Araki Y, Wang Z, Zang C, Wood WH, III, Schones D, et al. (2009) Genome-wide analysis of histone methylation reveals chromatin state-based regulation of gene transcription and function of memory CD8+ T cells. Immunity 30: 912-925.
66. Jiang X, Tan J, Li J, Kivimae S, Yang X, et al. (2008) DACT3 is an epigenetic regulator of Wnt/beta-catenin signaling in colorectal cancer and is a therapeutic target of histone modifications. Cancer Cell 13: 529-541.
67. Rodriguez J, Munoz M, Vives L, Frangou CG, Groudine M, et al. (2008) Bivalent domains enforce transcriptional memory of DNA methylated genes in cancer cells. Proc Natl Acad Sci U S A 105: 19809-19814.
68. Bapat SA, Jin V, Berry N, Balch C, Sharma N, et al. (2010) Multivalent epigenetic marks confer microenvironment-responsive epigenetic plasticity to ovarian cancer cells. Epigenetics 5: 716-729.
69. Muratovska A, Zhou C, He S, Goodyer P, Eccles MR, (2003) Paired-Box genes are frequently expressed in cancer and often required for cancer cell survival. Oncogene 22: 7989-7997.
70. Reka AK, Goswami MT, Krishnapuram R, Standiford TJ, Keshamouni VG, (2011) Molecular cross-regulation between PPAR-gamma and other signaling pathways: Implications for lung cancer therapy. Lung Cancer 72: 154-159.
71. Kerkhoff E, Fedorov LM, Siefken R, Walter AO, Papadopoulos T, et al. (2000) Lung-targeted expression of the c-Raf-1 kinase in transgenic mice exposes a novel oncogenic character of the wild-type protein. Cell Growth Differ 11: 185-190.
72. Segal E, Fondufe-Mittendorf Y, Chen L, Thastrom A, Field Y, et al. (2006) A genomic code for nucleosome positioning. Nature 442: 772-778.
73. Field Y, Kaplan N, Fondufe-Mittendorf Y, Moore IK, Sharon E, et al. (2008) Distinct modes of regulation by chromatin encoded through nucleosome positioning signals. PLoS Comput Biol 4: e1000216.
74. Xi L, Fondufe-Mittendorf Y, Xia L, Flatow J, Widom J, et al. (2010) Predicting nucleosome positioning using a duration Hidden Markov Model. BMC Bioinformatics 11: 346.
75. Stolz RC, Bishop TC, (2010) ICM Web: the interactive chromatin modeling web server. Nucleic Acids Res 38 Suppl pp. W254-W261.
76. Sikes ML, Bradshaw JM, Ivory WT, Lunsford JL, McMillan RE, et al. (2009) A streamlined method for rapid and sensitive chromatin immunoprecipitation. J Immunol Methods 344: 58-63.
77. Niehof M, Borlak J, (2005) RSK4 and PAK5 are novel candidate genes in diabetic rat kidney and brain. Mol Pharmacol 67: 604-611.